AI in Oncology Market
The AI in oncology market applies artificial intelligence to various stages of cancer management, including detection, screening, diagnosis, treatment, and drug discovery. Key customers include healthcare organizations, research institutions, and pharmaceutical companies. The market's growth is primarily driven by the rising global incidence of cancer, significant advancements in AI technologies like deep learning, and a surge in public and private investment in R&D.
CAGR
29.7%
Compound Annual Growth Rate
Current Value
$2.05B
Estimated 2026
Projected Value
$16.4B
By 2034